JOSEPH C. MCNAY

Business address
3 Bethesda Metro Center Ste 700, C/O Regenerx Biopharmaceuticals Inc, Bethesda, MD, 20814
Top holdings (ownership)
RGRX
⭐ Add to watchlist ⭐
Get insider transactions for this reporting owner
JOSEPH C. MCNAY has filed 32 SEC EDGAR filings since 01 Apr 2004

Latest Filings

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open Document Open Filing FORM 4 19 May 2022 17 May 2022 001-15070
4 Open Document Open Filing PRIMARY DOCUMENT 04 Aug 2021 02 Aug 2021 001-15070
4 Open Document Open Filing PRIMARY DOCUMENT 12 Jun 2020 10 Jun 2020 001-15070
4 Open Document Open Filing PRIMARY DOCUMENT 17 May 2019 15 May 2019 001-15070
4 Open Document Open Filing PRIMARY DOCUMENT 15 May 2019 13 May 2019 001-15070
4 Open Document Open Filing PRIMARY DOCUMENT 01 Mar 2019 27 Feb 2019 001-15070
4 Open Document Open Filing PRIMARY DOCUMENT 08 Jan 2019 06 Jan 2019 001-15070
4 Open Document Open Filing PRIMARY DOCUMENT 13 Sep 2018 11 Sep 2018 001-15070
4 Open Document Open Filing PRIMARY DOCUMENT 19 Jul 2018 17 Jul 2018 001-15070
4 Open Document Open Filing PRIMARY DOCUMENT 09 Jul 2018 05 Jul 2018 001-15070
4 Open Document Open Filing PRIMARY DOCUMENT 02 Apr 2018 29 Mar 2018 001-15070
4 Open Document Open Filing PRIMARY DOCUMENT 20 Oct 2017 19 Oct 2017 001-15070
4 Open Document Open Filing PRIMARY DOCUMENT 06 Sep 2017 01 Sep 2017 001-15070
4 Open Document Open Filing PRIMARY DOCUMENT 18 Mar 2016 16 Mar 2016 001-15070
4 Open Document Open Filing PRIMARY DOCUMENT 02 Jul 2015 30 Jun 2015 001-15070
4 Open Document Open Filing PRIMARY DOCUMENT 13 Feb 2015 29 Sep 2014 001-15070
SC 13D Open Document Open Filing SC 13D 29 Dec 2014
4 Open Document Open Filing FORM 4 SUBMISSION 01 Apr 2014 25 Mar 2014 001-15070
4 Open Document Open Filing FORM 4 SUBMISSION 09 Jan 2014 07 Jan 2014 001-15070